Mode
Text Size
Log in / Sign up
Phase 2 N=98 Randomized Treatment

Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Lung Cancer

Enrolled (actual)
98
Serious AEs
7.1%
Results posted
Jun 2021
Primary outcome: Primary: Incidence of AE Grade 3 or Higher Toxicity — 24; 26 Participants

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Arm 1 stereotactic body radiation therapy (Radiation); Arm II stereotactic body radiation therapy (Radiation)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Roswell Park Cancer Institute
Primary completion
May 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Incidence of AE Grade 3 or Higher Toxicity
24; 26
PRIMARY
Overall Survival
39.0; 38.3
PRIMARY
Correlation Between Blood and Serum Markers and Survival and Toxicity

Summary

RATIONALE: Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. It is not yet known which regimen of radiation therapy is more effective in treating patients with non-small cell lung cancer. PURPOSE: This randomized phase II trial is studying the side effects of two radiation therapy regimens and to see how well they work in treating patients with stage I or stage II non-small cell lung cancer.

Eligibility Criteria

Inclusion Criteria

  • Histologically confirmed non-small cell lung cancer
  • T1-T2, N0 disease measuring ≤ 5 cm( T3 tumor based on chest wall involvement is Excluded)
  • Surgically resectable primary disease, however patient evaluated by thoracic oncologist and deemed medically inoperable OR patient refuses surgical resection
  • Age >= 18

Exclusion Criteria

  • Prior thoracic radiation therapy
  • T2 or T3 tumor greater than 5 cm or T3 tumor based on chest wall involvement
  • Node positive or metastatic disease
  • Tumor location within the zone of the proximal bronchial tree. The proximal bronchial tree is defined as the carina, right and left main bronchi, right and left upper lobe bronchi, bronchus intermedius, right middle lobe bronchus, lingular bronchus, and right and left lower lobe bronchi. The zone of the proximal bronchial tree is defined as a volume 2cm in all directions around the proximal bronchial tree.
  • No other conditions deemed by the PI or associates to make the patient ineligible for protocol investigations, procedures, and high-dose external beam radiotherapy (e.g., unable to lie still and breathe reproducibly)
  • Pregnant or unwilling to use adequate contraception
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00843726). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search